Table 3

Standardized β-coefficients for associations between MVPA (min ⋅ day−1) and cardiometabolic risk factors

Characteristicsβ95% CIPR2
Model 1
 Waist (cm)−0.177−0.122, −0.134***0.2046
 Systolic BP (mmHg)−0.005−0.047, 0.0830.1915
 Diastolic BP (mmHg)−0.007−0.044, 0.0310.3441
 Fasting insulin (mU ⋅ L−1)−0.115−0.158, −0.072***0.1237
 Fasting glucose (mmol ⋅ L−1)−0.028−0.072, 0.0170.1645
 2-h plasma glucose (mmol ⋅ L−1)−0.069−0.112, −0.025**0.1108
 HbA1c (%)−0.046−0.096, 0.0040.1334
 HOMA-IR−0.122−0.166, −0.078***0.1235
 Triglycerides (mmol ⋅ L−1)−0.091−0.138, −0.044***0.0762
 Total cholesterol (mmol ⋅ L−1)−0.01−0.056, 0.0350.0952
 HDL (mmol ⋅ L−1)0.0550.009, 0.101*0.1808
 LDL (mmol ⋅ L−1)0.002−0.044, 0.0480.0567
 CRP (mg ⋅ L−1)−0.086−0.127, −0.045***0.262
Model 2
 Waist (cm)−0.127−0.173, −0.081***0.2215
 Systolic BP (mmHg)0.02−0.026, 0.0670.1961
 Diastolic BP (mmHg)0.011−0.03, 0.0530.3467
 Fasting insulin (mU ⋅ L−1) main effect−0.078−0.127, −0.03**0.1337
  25–45.9 years (reference)
  46.0–54.9 years0.025−0.120, 0.1700.1313
  55.0–71 years−0.098−0.195, −0.001*0.1313
 Fasting glucose (mmol ⋅ L−1)−0.014−0.063, 0.0350.1659
 2-h plasma glucose (mmol ⋅ L−1)−0.053−0.1, −0.006*0.1129
 HbA1c (%)−0.036−0.095, 0.0230.1345
 HOMA-IR−0.08−0.129, −0.031**0.1368
 Triglycerides (mmol ⋅ L−1)−0.067−0.117, −0.017**0.0804
 Cholesterol (mmol ⋅ L−1)−0.013−0.064, 0.0370.0953
 HDL (mmol ⋅ L−1)0.028−0.081, 0.3830.1867
 LDL (mmol ⋅ L−1)0−0.053, −0.0520.0572
 CRP (mmol ⋅ L−1)−0.061−0.108, −0.015**0.2665
  • Model 1 adjusted for age, sex, ethnicity, smoking, household income, education level, body fat%, wear time, sleep time, and intervention center. Model 2 additionally adjusted for ST.

  • *P < 0.05;

  • **P < 0.01;

  • ***P < 0.001.